Moreover, Oncomine showed that BIRC5 was significantly elevated in medullary breast carcinoma, invasive ductal breast carcinoma, invasive breast carcinoma, invasive ductal and invasive lobular breast carcinoma, breast carcinoma, invasive lobular breast carcinoma, and intraductal cribriform breast adenocarcinoma, compared with the corresponding normal tissues. Here, BIRC5 is linked to intraductal cribriform breast adenocarcinoma.